Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong · Delayed Price · Currency is HKD 6.30
+0.05 (0.80%)
Jul 10, 2026, 11:31 AM HKT
HKG:2566 Market Cap
HKG:2566 has a market cap or net worth of 1.51 billion as of July 9, 2026. Its market cap has decreased by -39.10% in one year.
Market Cap
1.51B
Enterprise Value
894.26M
Revenue
1.45B
Ranking
n/a
PE Ratio
9.96
Stock Price
6.30
Market Cap Chart
Since November 28, 2024, HKG:2566's market cap has decreased from 1.88B to 1.51B, a decrease of -19.59%. That is a compound annual growth rate of -12.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.51B | -18.64% |
| Dec 31, 2025 | 1.86B | 14.55% |
| Dec 31, 2024 | 1.62B | -13.73% |
| Nov 28, 2024 | 1.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PegBio | 2.22B |
| Frontage Holdings | 2.17B |
| Clover Biopharmaceuticals | 2.14B |
| AIM Vaccine | 2.07B |
| Mabpharm | 1.65B |
| SinoMab BioScience | 1.59B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.59B |
| HighTide Therapeutics | 1.49B |